Clinical Trial Update: Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update on the combination of olmesartan and hydrochlorothiazide for essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• olmesartan/hydrochlorothiazide (olmesartan; hydrochlorothiazide)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-04-20